Login to Your Account

Brain Illness Drug Market Largely Shunned by Investors

By Donna Young

Monday, July 21, 2008
The second fastest way to clear a room of venture capitalists and other investors is to announce a bomb threat or yell "fire." But the quickest way is to tell them you are a drug developer targeting traumatic brain injury (TBI) or stroke, said Harry Tracy, who runs Cardiff, Calif.-based NI Re-search, a consulting and research firm focused on the neurological and psychiatric therapeutics industry. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription